Haptena Therapeutics
ID: 17905926Haptena is a biotech company advancing a new paradigm in precision oncology for genetically defined tumors
1
Funding Rounds
$3.5m
Money raised
Recent Funding Rounds
Overview
Haptena is a biotech company advancing a new paradigm in precision oncology for genetically defined tumors
- Website:
- Headquarters: Turin
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Ch**** Am****** | - | - | |
| Ro***** Ch***** | - | - | - |
Funding series
Funding Series Analysis
The company Haptena Therapeutics has raised a total of $3.5m in funding over 1 rounds.
Key Insights:
- Haptena Therapeutics Seed Round, December 2025: $3.5m
Industries
Haptena Therapeutics is active in the following industries: